Neuronal vulnerability in Parkinson’s disease
- 1 January 1997
- book chapter
- Published by Springer Nature
- Vol. 50, 79-88
- https://doi.org/10.1007/978-3-7091-6842-4_9
Abstract
Although Parkinson’s disease is characterized by a loss of dopaminergic neurons in the substantia nigra not all dopaminergic neurons degenerate in this disease. This suggests that some specific factors make subpopulations of dopaminergic neurons more susceptible to the disease. Here, we show that the most vulnerable neurons are particularly sensitive to oxidative stress and rise in intracellular calcium concentrations. Because both events seem to occur in Parkinson’s disease this may explain why some dopaminergic neurons degenerate and other do not.Keywords
This publication has 31 references indexed in Scilit:
- Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?Brain Research, 1994
- Calpain is Implicated in Rat Myocardial Injury after Ischemia or ReperfusionJapanese Circulation Journal, 1994
- Distribution of 125I‐Ferrotransferrin Binding Sites in the Mesencephalon of Control Subjects and Patients with Parkinson's DiseaseJournal of Neurochemistry, 1993
- Calbindin-D28K in the basal ganglia of patients with parkinsonismAnnals of Neurology, 1992
- Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray MicroanalysisJournal of Neurochemistry, 1992
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray MicroanalysisJournal of Neurochemistry, 1991
- Decreased Ferritin Levels in Brain in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissueNeurobiology of Aging, 1990
- Superoxide dismutase and Parkinson's diseaseThe Lancet, 1990